Adjuvant therapy refers to additional treatments given after primary breast cancer surgery (like mastectomy or lumpectomy) to reduce the risk of the cancer returning. This therapy is a part of a comprehensive cancer treatment plan. It is typically used when there is a significant risk of recurrence based on the cancer's characteristics, such as its stage, grade, and hormone receptor status.
Patients suitable for adjuvant therapy typically include those who have undergone primary surgery for breast cancer and are assessed to be at risk of recurrence. The decision to recommend adjuvant therapy depends on several factors:
Breast oncology is a specialised field of medicine that focuses on the study and treatment of breast cancer. It encompasses a broad range of disciplines, including medical, surgical, and radiation oncology, all of which are dedicated to managing breast cancer from diagnosis to treatment and follow-up care.
Adjuvant therapies for breast cancer are diverse, each targeting different aspects of cancer treatment and patient care post-surgery. These therapies are crucial in reducing the risk of cancer recurrence and addressing the physical and emotional impacts of cancer diagnosis and treatment.
Chemotherapy involves the use of drugs to kill cancer cells, typically administered through the bloodstream to impact cancer cells throughout the body. It's particularly recommended for aggressive types of breast cancer or when cancer has a higher likelihood of spreading. Chemotherapy can be tailored based on the type of cancer, its stage, and other patient factors.
Radiotherapy (or radiation therapy) involves the use of high-energy rays to target and kill cancer cells. In breast cancer, radiotherapy is generally directed at the chest wall and the surrounding areas to destroy any remaining cancer cells after surgery. It is commonly recommended when the cancer is larger when it has spread to the lymph nodes, or after a lumpectomy to help prevent local recurrence.
Hormone therapy is used for hormone receptor-positive breast cancers, which grow in response to hormones like oestrogen and progesterone. This therapy may involve medications that block hormone receptors or drugs that lower hormone levels in the body. Common hormone therapies include tamoxifen for premenopausal women and aromatase inhibitors for postmenopausal women.
Targeted therapies involve drugs or other substances that attack cancer cells without affecting normal cells. For breast cancer, targeted therapy often focuses on the HER2 protein, which promotes the growth of cancer cells. Medications like trastuzumab (Herceptin) target and destroy HER2-positive cancer cells.
Physical therapy and exercises after breast cancer surgery help in recovering range of motion, reducing pain, and minimising lymphedema (swelling due to lymph fluid buildup). These exercises are crucial for restoring physical function and improving quality of life after treatment.
Psychological counselling and support groups play an essential role in helping patients cope with the emotional and psychological stress of a cancer diagnosis and treatment. Counseling can help address feelings of depression, anxiety, and fear, and support overall mental health.
Further investigations might be needed to assess the situation if any abnormalities or unusual symptoms arise during follow-up. These can include:
Adjuvant therapy involves several different types of treatments, each with specific procedures:
After completing adjuvant therapy, there are several outcomes and follow-up steps:
Generally, adjuvant therapy is designed to improve survival rates by reducing the risk of cancer recurrence. Studies have consistently shown that adjuvant therapy can significantly decrease the chance of breast cancer returning and can increase the overall survival rates, particularly in cancers that are aggressive or have higher risk factors like lymph node involvement or unfavourable hormone receptor status.
While adjuvant therapy plays a crucial role in treating breast cancer, it comes with potential risks and side effects, which can vary depending on the type of therapy:
The primary goal of adjuvant therapy is to eliminate any remaining cancer cells as soon as possible after surgery. Delaying therapy gives these cells a chance to grow and potentially metastasise, which can lead to cancer recurrence either locally or in distant organs. Delay in treatment can ultimately impact overall survival rates, particularly in aggressive types of breast cancer where the timing of therapy is crucial.
BREAST SURGERY
All Rights Reserved | Dr Railya Mousina